This Kind of Tech Can Make You Extraordinarily Wealthy

From the Editor: Michael's "$1 Million Giveaway" starts at 1 p.m. ET tomorrow. So if you haven't registered for his free, members-only webinar, click here. And get ready to hear about an incredible ground-floor tech opportunity. In the meantime, here's why Michael is so willing to share his research with us...

So far this year, the average technology IPO has gained some 60% from its offering price, handing investors hundreds of millions in new wealth.

Of course, by just about any standard, that's a pretty impressive accomplishment in its own right.

But in my world, the world of Silicon Valley venture capitalists, 60% gains are a nice way to get started on the road to lasting wealth.

The truth is, when it comes to achieving the kind of life-changing gains most people only dream about, high-tech is the one area that investors can consistently count on over the long haul.

Just look at the hundreds of billions in new wealth created by the transistor, the Space Race, semiconductors, personal computers, the Internet, smartphones, and new biotech molecules.

And that's only a small part of a very long list of technology that turned entrepreneurs into billionaires and average investors into millionaires seemingly overnight.

Indeed, tech's extraordinary profit potential is why I began doing all of this research for you in the first place...

This Is the Greatest Wealth Generator in History

There has simply never been a better time in the history of the stock market to be a tech investor than right now.

In fact, the tech sector ranks as the driving force in today's incredible bull market that has brought the S&P 500 to dizzying new heights.

Examples are everywhere...

Take the case of ARM Holdings plc (ADR) (Nasdaq: ARMH). It's a semiconductor firm that designs chips for mobile products like smartphones and tablet computers.

In the past five years, the stock is up more than 840%, turning $25,000 into $237,500. Not bad for a stock that still trades for less than $50 a share and that is riding an unstoppable trend - mobile is outselling PCs by a factor of 5-to-1.

During the same five years, a small-cap play on high-speed digital networks did almost as well. Alliance Fiber Optic Products Inc. (Nasdaq: AFOP) has rallied nearly 785%, turning $25,000 into $221,250.

Alliance still faces a very bright future, indeed. Because of all of the web content, and the explosion in mobile devices, the world simply needs much faster computer networks. Trading at right around $17 a share, Alliance still has plenty of room to run.

And consider what happened with Stratasys Ltd. (Nasdaq: SSYS). The company helped pioneer the breakthrough field of 3D printing. This is technology that allows users to "print" out physical goods like car and aircraft parts, dental implants, and architectural models, saving millions in design and preproduction costs.

Had you put $25,000 into Stratasys five years ago, you'd be sitting on $238,750 today - a total return of more than 855%.

Of course, as much as I love making money, I find technology fascinating for its own sake. I'm as passionate about as my iPhone as I was the first transistor radio I got as a little boy decades ago.

I Was Born to Do This

You could say that tech is in my DNA...

See, I grew up in a defense technology household. My brother is the CEO of a satellite communications company. And my dad is a retired Marine Corps officer, who became the senior military editor of Aviation Week & Space Technology.

So, while other young men were chatting about sports with their dads, I was talking about supercomputers, gallium arsenide semiconductors, sensors, directed-energy weapons, advanced radar, and satellite communications.

In fact, as a young analyst, I relocated from Detroit to the San Francisco Bay Area in the mid-1980s to pursue my passion for racing sailboats... and to be near Silicon Valley, the greatest wealth machine in the history of the human race.

To this day it never ceases to amaze me just how much money there is to be made in Silicon Valley, as new tech firms start up all the time.

Here's a visual that will paint a vivid portrait of what I'm talking about.

As you drive past all those business parks and office buildings, it's easy to see which companies have just gone public. They're the ones with lots of shiny new cars, including plenty of BMWs and Porsches.

Sadly, there's a huge disconnect between Silicon Valley's riches and the average American's net worth...

A recent page-one story in the Wall Street Journal noted that most U.S. workers have only about $25,000 in actual savings. That's nowhere near the amount of money they will need for a healthy retirement account that will get them comfortably through their golden years.

But I'm here to help...

Together, we'll go after some of the biggest gains ever seen.

855% Gains Are Just the Beginning

I serve as the editor of Radical Technology Profits. It's an aggressive trading service focused on breakthrough technology that can make subscribers a lot of money in a short amount of time.

The service capitalizes on my 35 years of analyzing technology, of going to top U.S. research labs and meeting with high-level industry executives.

I sharpened those skills while serving as a strategic consultant to Silicon Valley startups. I also worked as a senior advisor to the venture capital firm Sensei Partners LLC.

Those many years of experience pay off well for our readers.

At Radical Technology Profits, for example, I combine this experience with a unique technical trading system.

The charting approach we use to find low-priced, fast-moving tech shares, my Real Demand Tracking System, is set up to find stocks like:

  • Santarus Inc. (Nasdaq: SNTS): Shares of this small-cap biotech firm have gained 835% over the past five years.
  • Cray Inc. (Nasdaq: CRAY): This small-cap leader in high-performance computing gave shareholders a five-year return of 855%.
  • Align Technology Inc. (Nasdaq: ALGN): Over the past five years, share of this mid-cap medical device firm are up some 720%.

As impressive as these gains are, the opportunity I'm closely watching today could be among the greatest we'll see in our lifetimes.

That's why I'm hosting the webinar Thursday. I can't wait to show you what's about to happen.

You can register for the big event right here. It's free.

About the Author

Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...

  • He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
  • He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
  • As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael's insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.

Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

And even with decades of experience, Michael believes there has never been a moment in time quite like this.

Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.

To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.

His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.

Read full bio